Get started
Author

Matilde Scaldaferri

Observed names: M Scaldaferri, M. Scaldaferri, Scaldaferri, Matilde
ORCID: 0000-0002-5210-9783
Observed ORCID: 0000-0002-5210-9783
OpenAlex ID: A5021262095
Ozone therapy in COVID-19: A narrative review
2020 · Francesco Cattel, Susanna Giordano, et al. · Virus Research · 82
Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury
2021 · Francesco Cattel, Susanna Giordano, et al. · Respiratory Physiology & Neurobiology · 44
Immunomodulatory and clinical effects of daratumumab in T‐cell acute lymphoblastic leukaemia
2020 · Marco Cerrano, Barbara Castella, et al. · British Journal of Haematology · 20
PDF
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma
2022 · Francesca Bonello, Serena Rocchi, et al. · Frontiers in Oncology · 13
PDF
Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia
2022 · Semra Aydin, Roberto Passera, et al. · International Journal of Hematology · 11
PDF
Impact of Allogeneic Stem Cell Transplantation on Testicular and Sexual Function
2020 · Marco Zavattaro, Francesco Felicetti, et al. · Transplantation and Cellular Therapy · 10
Adherence to oral chemotherapy: Evidence from a randomised clinical trial
2020 · Ada Ghiggia, Alessandra Bianco, et al. · European Journal of Cancer Care · 8
PDF
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation
2020 · Vincenzo Apolito, Luisa Giaccone, et al. · Annals of Hematology · 8
Adherence, persistence and efficacy of dasatinib and nilotinib in the treatment of patients resistant or intolerant to imatinib with chronic myeloid leukemia in chronic phase: an Italian multicenter study over two years in real life
2021 · Fiorenzo Santoleri, Elena Ranucci, et al. · Current Medical Research and Opinion · 6
Medicine recovery and reuse in a hospital setting: a lesson from Italy
2022 · Maria Michela Gianino, Valentina Cotugno, et al. · International Journal of Pharmacy Practice · 5
Case Report: Iatrogenic dyspnea and respiratory failure in a multiple myeloma patient treated with carfilzomib
2025 · Giuseppe Bertuglia, Mattia Verardo, et al. · Frontiers in Oncology · 2
PDF
Arsenic trioxide neurotoxicity in acute promyelocytic leukemia patients: a single center experience
2024 · G. Arrigo, M. Scaldaferri, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2
4CPS-215 Access to ‘fondo AIFA 5%’ as an instrument supporting the sustainability in a shared clinical management of rare and difficult-to-treat diseases
2019 · G Valinotti, M Scaldaferri, et al. · European Journal of Hospital Pharmacy · 2
PDF
Bortezomib-melphalan-prednisone (VMP) +/- daratumumab (DVMP) vs. lenalidomide-dexamethasone (Rd) +/- daratumumab (DRd) in transplant-ineligible real-life multiple myeloma patients: Results from the randomized phase IV real MM trial
2025 · Mattia D'Agostino, Sara Bringhen, et al. · Blood · 1
THU-486-YI A multi-center comparison of Atezolizumab plus Bevacizumab and Lenvatinib as primary systemic therapy for unresectable hepatocellar carcinoma: focus on thrombotic and hemorragic adverse events
2024 · Marco Tizzani, Chiara Mazzarelli, et al. · Journal of Hepatology · 1
5PSQ-158 Off-label use of pembrolizumab in PD-L1 positive metastatic anaplastic thyroid carcinoma: a case report
2021 · SMA Giordano, M Scaldaferri, et al. · European Journal of Hospital Pharmacy · 1
PDF
A Comparative Study of Biosimilar Filgrastim Versus Originator G-CSF for CD34+ Cells Mobilization and Autografting in Hematological Malignancies
2016 · Lucia Brunello, Luisa Giaccone, et al. · Blood · 1
DI-071 Everolimus (AFINITOR): a case of steatosis in the treatment of pancreatic neuroendocrine tumours
2015 · M Scaldaferri, E Castellana, et al. · European Journal of Hospital Pharmacy · 1
Esperienza di collaborazione interdisciplinare farmacista di reparto-ematologo per la gestione della terapia antifungina sistemica in un reparto di ematologia
2011 · M Scaldaferri, Elisa Sciorsci, et al. · Bollettino SIFO · 1
Circulating tumor plasma cells quantification in newly diagnosed transplant ineligible real world multiple myeloma patients: Comparison of single‐platform flow cytometry versus next generation flow
2026 · Elona Saraci, Alessandra Larocca, et al. · Cytometry Part B Clinical Cytometry
PDF
Vyxeos® liposomal e Leucemia Acuta Mieloide: Health Technology Assessment e Valutazioni di Costo/Efficacia
2026 · Valinotti, Giulia, Varese, Alessandra, et al. · Zenodo (CERN European Organization for Nuclear Research)
P14 | Daratumumab-bortezomib-melphalan-prednisone Vs. Daratumumab-lenalidomide-dexamethasone in Transplant-ineligible Real-life Patients With Multiple Myeloma: a Subanalysis of the Phase Iv Real Mm Trial
2026 · L. Cani, S. Bringhen, et al. · Haematologica
PDF
FAR-BENE Study: pharmacoeconomics and well-being in hemophilia. Monitoring outcomes in light of pharmaceutical expenditure with focus on patients undergoing therapeutic switch.
2026 · Carola Sella, Federica Valeri, et al. · Europe PMC (PubMed Central)
Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica
2025 · Anna Amela Valsecchi, Matilde Scaldaferri, et al. · Tumori Journal
PDF
FAR-BENE Study: pharmacoeconomics and well-being in hemophilia. Monitoring outcomes in light of pharmaceutical expenditure with focus on patients undergoing therapeutic switch: FAR-BENE Study
2025 · Sella, Carola, Valeri, Federica, et al. · Blood transfusion
PDF
Works count: 57
Citation count: 219
H-index: 8
I10-index: 6
Year
Topic
Type